CD36 c.1264 T>G Null Mutation Impairs Acquisition of IgG Antibodies to Plasmodium falciparum MSP1- 19 Antigen and is Associated with Higher Malaria Incidences in Tanzanian Children

Scandinavian Journal of Immunology

Volumn 75, Issue 3, 2012, Pages 355-360

  Kajeguka, D ^a,b   Mwanziva, C ^a,b   Daou, M ^b,c   Ndaro, A ^b   Matondo, S ^b   Mbugi, E ^d   Dolmans, W ^e   Chilongola, J ^a,b  

^a KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^b KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^c Malaria Research Training Centre   (Mali)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; GLYCINE; IMMUNOGLOBULIN G ANTIBODY; MEROZOITE SURFACE PROTEIN 1; THREONINE;

AMINO ACID SUBSTITUTION; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NULL ALLELE; OPTICAL DENSITY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TANZANIA;

ANTIBODIES, PROTOZOAN; ANTIGENS, CD36; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TANZANIA;

EID: 84856834222     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02661.x     Document Type: Article

References (27)

1. Amodu OK, Gbadegesin RA, Ralph SA et al. Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Acta Trop 2005;95:248-55.
2. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005;77:171-92.
3. Sherman IW, Eda S, Winograd E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect 2003;5:897-909.
4. Newbold C, Warn P, Black G et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 1997;57:389-98.
5. Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol 2000;11:483-91.
6. Ho M, Hoang HL, Lee KM et al. Ectophosphorylation of CD36 regulates cytoadherence of Plasmodium falciparum to microvascular endothelium under flow conditions. Infect Immun 2005;73:8179-87.
7. Mo M, Lee HC, Kotaka M et al. The C-terminal segment of the cysteine-rich interdomain of Plasmodium falciparum erythrocyte membrane protein 1 determines CD36 binding and elicits antibodies that inhibit adhesion of parasite-infected erythrocytes. Infect Immun 2008;76:1837-47.
8. Podrez EA, Poliakov E, Shen Z et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 2002;277:38503-16.
9. Helming L, Winter J, Gordon S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci 2009;122:453-9.
10. Good MF, Doolan DL. Immune effector mechanisms in malaria. Curr Opin Immunol 1999;11:412-9.
11. Good MF. Towards a blood-stage vaccine for malaria: are we following all the leads? Nat Rev Immunol 2001;1:117-25.
12. Narden E, Zavala F. Acquired immunity to malaria. In: Sherman IW, ed. Malaria: Parasite Biology, Pathogenesis and Protection. Washington DC: ASM Press, 1998:495-512.
13. Hoebe K, Georgel P, Rutschmann S et al. CD36 is a sensor of diacylglycerides. Nature 2005;433:523-7.
14. Dodoo D, Aikins A, Kusi KA et al. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J 2008;7:142.
15. Diggs CL, Ballou WR, Miller LH. The major merozoite surface protein as a malaria vaccine target. Parasitol Today 1993;9:300-2.
16. Good MF, Kaslow DC, Miller LH. Pathways and strategies for developing a malaria blood-stage vaccine. Annu Rev Immunol 1998;16:57-87.
17. Blackman MJ, Ling IT, Nicholls SC, Holder AA. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol 1991;49:29-33.
18. Blackman MJ, Scott-Finnigan TJ, Shai S, Holder AA. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J Exp Med 1994;180:389-93.
19. Pan W, Ravot E, Tolle R et al. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells. Nucleic Acids Res 1999;27:1094-103.
20. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 1991;10:506-13.
21. Cavanagh DR, Dobano C, Elhassan IM et al. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun 2001;69:1207-11.
22. Fry AE, Ghansa A, Small KS et al. Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet 2009;18:2683-92.
23. Chilongola J, Balthazary S, Mpina M, Mhando M, Mbugi E. CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health 2009;14:810-6.
24. Curtis BR, Aster RH. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion 1996;36:331-4.
25. Serghides L, Smith TG, Patel SN, Kain KC. CD36 and malaria: friends or foes? Trends Parasitol 2003;19:461-9.
26. Campos MA, Almeida IC, Takeuchi O et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001;167:416-23.
27. O'Donnell RA, de Koning-Ward TF, Burt RA et al. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 2001;193:1403-12.